Fresenius Kabi

NEBUPENT - Cost

Updated as of: July 1st, 2024

HCPCS:

J2545

HCPCS Code Descriptor:

Pentamidine isethionate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 300 mg

Medicare Payment Limit:

The Nebupent Medicare Payment Limit is $85.814.

Average Sale Price:

NEBUPENT ASP cost available once logged in.

Medicare Co-Insurance Percentage:

The Nebupent Medicare Co-Insurance percentage is 20%. Nebupent's Medicare Co-Insurance amount is $17.163

APC Code:

The Nebupent APC Code is: not available

APC Payment Limit:

The APC Payment Limit for NEBUPENT is not available.

Nebupent Cost Information:

NEBUPENT, manufactured by Fresenius Kabi, became effective on January 1, 2008, and is aligned to HCPCS J2545. NEBUPENT has five NDCs aligned to J2545 with a couple potential errors associated with these mappings. Pricing has remained somewhat level until the end of 2023 when WAC and AWP both had moderated decreases.

ACCESS PRICING AND MORE BY REGISTERING

Nebupent’s wholesale acquisition cost (WAC) information was last updated on:
October 11, 2019
Nebupent’s average wholesale price (AWP) information was last updated on:
October 11, 2019